Cbz-LR-AMC

Ref. 3D-PP46297

Informations sur le produit

• Nom: Cbz-LR-AMC
• Synonymes: Cbz-Leu-Arg-Ala-Met-Cys

Description

Peptide Cbz-LR-AMC is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Cbz-LR-AMC include the following: Generation of antibodies directed against the low-immunogenic peptide-toxins microcystin-LR/RR and nodularin W Baier, M Loleit, B Fischer, G Jung - International journal of , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0192056199000867 on amino acids and peptides-III. 2, 4-bis (4-methoxyphenyl)-1, 3, 2, 4-dithiadiphosphetane 2, 4-disulfide, LR, as a new racemization free coupling reagent in peptide U Pedersen, M Thorsen, EEAM El-Khrisy, K Clausen - Tetrahedron, 1982 - Elsevierhttps://www.sciencedirect.com/science/article/pii/004040208280104X Systematically studying the optimal amino acid distribution patterns of the amphiphilic structure by using the ultrashort amphiphiles S He, Z Yang, W Yu, J Li, Z Li, J Wang - Frontiers in , 2020 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fmicb.2020.569118/full Conformational propensity and biological studies of proline mutated LR peptides inhibiting human thymidylate synthase and ovarian cancer cell growth. S Ferrari - iris.unife.ithttps://iris.unife.it/bitstream/11392/2406160/4/11392_2406160_postprint_Guerrini_Remo.pdf of Anti-Plasmodial Activity of Non-Hemolytic, Non-Immunogenic, Non-Toxic Antimicrobial Peptides (AMPs LR14) Produced by Lactobacillus plantarum LR/14 R Gupta, V Rajendran , PC Ghosh , S Srivastava - Drugs in R&D, 2014 - Springerhttps://link.springer.com/article/10.1007/s40268-014-0043-y Conformational propensity and biological studies of proline mutated LR peptides inhibiting human thymidylate synthase and ovarian cancer cell growth P Saxena, L Severi, M Santucci, L Taddia - Journal of Medicinal , 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.7b01699 Synthesis of folic conjugated LR octapeptide M Pela, C Trapella , R Guerrini, S Salvadori - Symposium on Folate , 2012 - sfera.unife.ithttps://sfera.unife.it/handle/11392/2295819 Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides M Gurrath, G Muller, H Kessler - European Journal of , 1992 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1432-1033.1992.tb17495.x Application of Anti-LRP/LR Specific Antibodies for the Treatment of Alzheimer's Disease K Jovanovic - 2014 - wiredspace.wits.ac.zahttps://wiredspace.wits.ac.za/bitstreams/b227a515-421c-4b64-a319-0c6fdabaaf24/download A nonempirical method using LC/MS for determination of the absolute configuration of constituent amino acids in a peptide: combination of Marfey's method with mass K Fujii, Y Ikai, H Oka, M Suzuki, K Harada - Analytical Chemistry, 1997 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac970289b Enzymatic pathway for the bacterial degradation of the cyanobacterial cyclic peptide toxin microcystin LR DG Bourne , GJ Jones , RL Blakeley - Applied and , 1996 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/aem.62.11.4086-4094.1996 The 37/67kDa laminin receptor (LR) inhibitor, NSC47924, affects 37/67kDa LR cell surface localization and interaction with the cellular prion protein D Sarnataro , A Pepe, G Altamura , I De Simone - Scientific reports, 2016 - nature.comhttps://www.nature.com/articles/srep24457

• Marque: Biosynth